Neoindicate
Wellington, US · 1 known investors
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
BiotechHealthtechMedical Devices